Table 1.
Patient characteristics by presence or absence of treatment delay
| Patients receiving timely treatment n=7245 | Patients receiving delayed treatment n=1205 | P-value | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Total | 7245 | 100.0% | 1205 | 100.0% | |
| Age at diagnosis | |||||
| 65 – 69 years | 1940 | 26.8% | 390 | 32.4% | |
| 70 – 74 years | 2065 | 28.5% | 369 | 30.6% | <0.001 |
| 75 – 79 years | 1727 | 23.8% | 232 | 19.3% | |
| 80 years and older | 1513 | 20.9% | 214 | 17.8% | |
| Gender | |||||
| Female | 2382 | 32.9% | 393 | 32.6% | 0.86 |
| Male | 4863 | 67.1% | 812 | 67.4% | |
| Race and ethnicity | |||||
| White | 4986 | 68.8% | 771 | 64.0% | |
| Black | 498 | 6.9% | 124 | 10.3% | <0.001 |
| Asian | 967 | 13.3% | 165 | 13.7% | |
| Hispanic | 276 | 3.8% | 61 | 5.1% | |
| Other/Unknown | 518 | 7.1% | 84 | 7.0% | |
| Neighborhood-level SES | |||||
| Low poverty neighborhoods | 3558 | 49.1% | 518 | 43.0% | <0.001 |
| Moderate poverty neighborhoods | 2093 | 28.9% | 381 | 31.6% | |
| High poverty neighborhoods | 1594 | 22.0% | 306 | 25.4% | |
| Geographic region | |||||
| Northeast | 1338 | 18.5% | 228 | 18.9% | |
| West | 3792 | 52.3% | 696 | 57.8% | <0.001 |
| Midwest | 691 | 9.5% | 101 | 8.4% | |
| South | 1424 | 19.7% | 180 | 14.9% | |
| Metropolitan status | |||||
| Metro > 1 million | 4549 | 62.8% | 750 | 62.2% | |
| Metro 250,000 – 1 million | 1415 | 19.5% | 255 | 21.2% | 0.02 |
| Metro <250,000 | 522 | 7.2% | 103 | 8.5% | |
| Non-Metro | 759 | 10.5% | 97 | 8.0% | |
| Tumor Staging | |||||
| Unifocal <=5 cm without vascular invasion and metastasis | 1642 | 22.7% | 310 | 25.7% | |
| Beyond unifocal without vascular invasion and metastasis | 3605 | 49.8% | 641 | 53.2% | |
| Vascular invasion or metastasis | 313 | 4.3% | 50 | 4.1% | <0.001 |
| Non-determinable | 1685 | 23.3% | 204 | 16.9% | |
| SEER stage | |||||
| Localized | 4531 | 62.5% | 751 | 62.3% | |
| Regional | 1753 | 24.2% | 298 | 24.7% | 0.01 |
| Distant | 766 | 10.6% | 90 | 7.5% | |
| Unknown | 375 | 5.2% | 66 | 5.5% | |
| NCI comorbidity index | |||||
| 0 | 1566 | 21.6% | 237 | 19.7% | |
| 1 | 1601 | 22.1% | 218 | 18.1% | |
| 2 | 1422 | 19.6% | 245 | 20.3% | 0.001 |
| 3 | 1315 | 18.2% | 259 | 21.5% | |
| 4 | 405 | 5.6% | 85 | 7.1% | |
| >=5 | 936 | 12.9% | 161 | 13.4% | |
| Liver disease etiology | |||||
| HCV | 2175 | 30.0% | 448 | 37.2% | |
| HBV | 402 | 5.5% | 59 | 4.9% | |
| Alcohol related liver disease | 737 | 10.2% | 137 | 11.4% | <0.001 |
| Other liver diseases | 148 | 2.0% | 25 | 2.1% | |
| MAFLD | 2705 | 37.3% | 372 | 30.9% | |
| No identifiable liver disease | 1078 | 14.9% | 164 | 13.6% | |
| Liver dysfunction | |||||
| Presence of hepatic encephalopathy | 476 | 6.6% | 80 | 6.6% | 0.93 |
| Presence of ascites | 900 | 12.4% | 149 | 12.4% | 0.96 |